216 related articles for article (PubMed ID: 20097486)
1. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer.
Roeloffzen EM; Lips IM; van Gellekom MP; van Roermund J; Frank SJ; Battermann JJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1054-60. PubMed ID: 20097486
[TBL] [Abstract][Full Text] [Related]
2. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
[TBL] [Abstract][Full Text] [Related]
4. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
Feigenberg SJ; Lee WR; Desilvio ML; Winter K; Pisansky TM; Bruner DW; Lawton C; Morton G; Baikadi M; Sandler H
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):956-64. PubMed ID: 15989995
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification.
Lips IM; van Gils CH; van der Heide UA; Kruger AE; van Vulpen M
BJU Int; 2009 Mar; 103(6):762-7. PubMed ID: 18990145
[TBL] [Abstract][Full Text] [Related]
7. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
11. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
[TBL] [Abstract][Full Text] [Related]
12. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150.
Vordermark D; Noe M; Markert K; Wulf J; Müller G; Bratengeier K; Beckmann G; Baier F; Guckenberger M; Schiefelbein F; Schön G; Flentje M; Baier K
Radiother Oncol; 2009 May; 91(2):217-24. PubMed ID: 19136175
[TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
Stone NN; Stock RG
Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
[TBL] [Abstract][Full Text] [Related]
15. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.
Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL
J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer.
Galalae RM; Loch T; Riemer B; Rzehak P; Küchler T; Kimmig B; Kovács G
Strahlenther Onkol; 2004 Sep; 180(9):582-9. PubMed ID: 15378189
[TBL] [Abstract][Full Text] [Related]
17. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
19. Quality of life outcomes after brachytherapy for early stage prostate cancer.
Brandeis JM; Litwin MS; Burnison CM; Reiter RE
J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
[TBL] [Abstract][Full Text] [Related]
20. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
